CAR-T cell therapy for cancer causes “brain fog”
New research shows CAR-T cell therapy causes mild cognitive impairment via the same cellular mechanism as chemotherapy and respiratory infections like the flu and COVID-19. …
New research shows CAR-T cell therapy causes mild cognitive impairment via the same cellular mechanism as chemotherapy and respiratory infections like the flu and COVID-19. …
Mutations in the TARDBP gene that lower TDP-43 protein levels damage brain blood vessel endothelial cells, disrupting the blood-brain barrier and contributing to diseases like Alzheimer’s, frontotemporal dementia, and ALS. …
A new study finds that macrophages from individuals with autism have a significantly impaired ability to clear synaptic proteins. …
New study finds that interactions between immune and brain cells drive fear responses, but treatment with psychedelics like MDMA and psilocybin may reverse these effects. …
Researchers investigated whether genetic risk for schizophrenia is associated with changes in retinal nerve connections, as the retina is a direct extension of the brain and may reflect brain alterations related to the disorder. …
Preclinical study reveals that specific neurons connect cancer-related brain inflammation to loss of motivation in advanced cancer and that blocking this pathway can restore motivation. …
Study finds that people with cannabis use disorder (CUD) have increased dopamine levels in a brain region associated with psychosis. …
New research on the IL-17 cytokine adds to growing evidence that immune molecules can influence behavior during illness. …
A drug typically prescribed for arthritis halts brain-damaging seizures in a mouse model of chronic epilepsy. …
Rejuvenating the brain’s waste-removal system can enhance memory in aging mice, potentially offering a new approach to combat neurodegenerative diseases like Alzheimer’s and Parkinson’s. …
End of content
End of content